NCT01952678 - Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET) | Biotech Hunter

Enrollment

204

Participants

Timeline

Start Date

July 30, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Essential TremorParkinson's Disease

Interventions

OTHER

DaTscan™ - Non-Caucasian Participants

Participants who previously administered DaTscan™ and had undergone SPECT imaging of the brain per local practice at each institution.

OTHER

DaTscan™ - Caucasian Participants

Participants who previously administered DaTscan™ and had undergone SPECT imaging of the brain per local practice at each institution.

Trial Locations (1)

GE Healthcare, Marlborough